943
Views
51
CrossRef citations to date
0
Altmetric
Review Article

Nanoneurotherapeutics approach intended for direct nose to brain delivery

, , &
Pages 1922-1934 | Received 12 Jan 2015, Accepted 07 May 2015, Published online: 09 Jun 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

Luyun Cai, Miaoyu Gan, Joe M. Regenstein & Qian Luan. (2023) Improving the biological activities of astaxanthin using targeted delivery systems. Critical Reviews in Food Science and Nutrition 0:0, pages 1-22.
Read now
Shourya Tripathi, Ujala Gupta, Rewati Raman Ujjwal & Awesh K. Yadav. (2021) Nano-lipidic formulation and therapeutic strategies for Alzheimer’s disease via intranasal route. Journal of Microencapsulation 38:7-8, pages 572-593.
Read now
Andrea Perrelli, Parisa Fatehbasharzad, Valerio Benedetti, Chiara Ferraris, Marco Fontanella, Elisa De Luca, Mauro Moglianetti, Luigi Battaglia & Saverio Francesco Retta. (2021) Towards precision nanomedicine for cerebrovascular diseases with emphasis on Cerebral Cavernous Malformation (CCM). Expert Opinion on Drug Delivery 18:7, pages 849-876.
Read now
Saleha Rehman, Bushra Nabi, Ameeduzzafar Zafar, Sanjula Baboota & Javed Ali. (2019) Intranasal delivery of mucoadhesive nanocarriers: a viable option for Parkinson’s disease treatment?. Expert Opinion on Drug Delivery 16:12, pages 1355-1366.
Read now
David Lembo, Manuela Donalisio, Andrea Civra, Monica Argenziano & Roberta Cavalli. (2018) Nanomedicine formulations for the delivery of antiviral drugs: a promising solution for the treatment of viral infections. Expert Opinion on Drug Delivery 15:1, pages 93-114.
Read now
Oscar Escalona-Rayo, Paulina Fuentes-Vázquez, Gerardo Leyva-Gómez, Bulmaro Cisneros, Rafael Villalobos, Jonathan J. Magaña & David Quintanar-Guerrero. (2017) Nanoparticulate strategies for the treatment of polyglutamine diseases by halting the protein aggregation process. Drug Development and Industrial Pharmacy 43:6, pages 871-888.
Read now

Articles from other publishers (44)

Afiya Furquan, Abdul Hafeez & Md. Azizur Rahman. (2023) Brain targeting of drugs via intranasal route in conjunction with nanoparticle-based systems: an updated review. Journal of Nanoparticle Research 25:11.
Crossref
Shalu Singh & Rahul Shukla. (2023) Nanovesicular-Mediated Intranasal Drug Therapy for Neurodegenerative Disease. AAPS PharmSciTech 24:7.
Crossref
Prativa Das, Jnyana Ranjan Panda, Ch Niranjan Patro, Baby Sahu & Soumya Stuti Patnaik. (2023) A Comprehensive Review of Nanoemulsion Applications and their Recent Advancements. Current Nanomaterials 8:3, pages 209-223.
Crossref
Prakash N. Kendre, Dhiraj R. Kayande, Shirish P. Jain, Tejaswini G. Malge, Namrata N. Zadpe & Bhupendra G. Prajapati. (2023) Polymeric Nanoparticles: Prospective on the Synthesis, Characterization and Applications in Nose-to-Brain Drug Delivery. Current Nanoscience 19:5, pages 663-676.
Crossref
C. SOWMYA, SURIYA PRAKAASH K. K.ABRAR AHMED H.. (2023) SOLID LIPID NANOPARTILCES: MODERN PROGRESS IN NOSE-TO-BRAIN TRANSDUCTION. International Journal of Applied Pharmaceutics, pages 20-26.
Crossref
Patrícia C. Pires, Mariana Fernandes, Francisca Nina, Francisco Gama, Maria F. Gomes, Lina E. Rodrigues, Sara Meirinho, Samuel Silvestre, Gilberto Alves & Adriana O. Santos. (2023) Innovative Aqueous Nanoemulsion Prepared by Phase Inversion Emulsification with Exceptional Homogeneity. Pharmaceutics 15:7, pages 1878.
Crossref
Shiv Bahadur & Anubhav Prakash. (2023) A Comprehensive Review on Nanomedicine: Promising Approach for Treatment of Brain Tumor through Intranasal Administration. Current Drug Targets 24:1, pages 71-88.
Crossref
Angela Maria Mathew, Saatheeyavaane Bhuvanendran, Rajesh Sreedharan Nair & Ammu K Radhakrishnan. (2023) Exploring the anti-inflammatory activities, mechanism of action and prospective drug delivery systems of tocotrienol to target neurodegenerative diseases. F1000Research 12, pages 338.
Crossref
María L. Formica, Daniel A. Real, Matías L. Picchio, Elise Catlin, Ryan F. Donnelly & Alejandro J. Paredes. (2022) On a highway to the brain: A review on nose-to-brain drug delivery using nanoparticles. Applied Materials Today 29, pages 101631.
Crossref
E. V. Loseva, N. A. Loginova, L. I. Russu & M. V. Mezentseva. (2022) Behavior of Rats in Tests for Anxiety after a Short Intranasal Injection of Single-Walled Carbon Nanotubes in Two Small Doses. Journal of Evolutionary Biochemistry and Physiology 58:6, pages 1973-1986.
Crossref
Francisco J. Padilla-Godínez, Leonardo I. Ruiz-Ortega & Magdalena Guerra-Crespo. (2022) Nanomedicine in the Face of Parkinson’s Disease: From Drug Delivery Systems to Nanozymes. Cells 11:21, pages 3445.
Crossref
Dyandevi MathureHemantkumar RanpiseRajendra Awasthi & Atmaram Pawar. (2022) Formulation and Characterization of Nanostructured Lipid Carriers of Rizatriptan Benzoate-Loaded In Situ Nasal Gel for Brain Targeting . ASSAY and Drug Development Technologies 20:5, pages 211-224.
Crossref
Elisabetta Muntoni, Elisabetta Marini, Chiara Ferraris, Sara Garelli, Maria Teresa Capucchio, Elena Colombino, Pier Paolo Panciani & Luigi Battaglia. (2022) Intranasal lipid nanocarriers: Uptake studies with fluorescently labeled formulations. Colloids and Surfaces B: Biointerfaces 214, pages 112470.
Crossref
Rajalakshmi Rajendran, Krishnakumar Neelakandha MenonSreeja Chandrasekharan Nair. (2021) Nanotechnology Approaches for Enhanced CNS Drug Delivery in the Management of Schizophrenia. Advanced Pharmaceutical Bulletin 12:3, pages 490-508.
Crossref
M.S. Sudheesh & Rajesh Singh Pawar. 2022. Nanomedical Drug Delivery for Neurodegenerative Diseases. Nanomedical Drug Delivery for Neurodegenerative Diseases 207 222 .
David Lee & Tamara Minko. (2021) Nanotherapeutics for Nose-to-Brain Drug Delivery: An Approach to Bypass the Blood Brain Barrier. Pharmaceutics 13:12, pages 2049.
Crossref
Md. Rizwanullah, Mohammad Zaki Ahmad, Anuj Garg & Javed Ahmad. (2021) Advancement in design of nanostructured lipid carriers for cancer targeting and theranostic application. Biochimica et Biophysica Acta (BBA) - General Subjects 1865:9, pages 129936.
Crossref
Laura Deruyver, Clément Rigaut, Pierre Lambert, Benoît Haut & Jonathan Goole. (2021) The importance of pre-formulation studies and of 3D-printed nasal casts in the success of a pharmaceutical product intended for nose-to-brain delivery. Advanced Drug Delivery Reviews 175, pages 113826.
Crossref
Hussein Akel, Ruba Ismail, Gábor Katona, Fakhara Sabir, Rita Ambrus & Ildikó Csóka. (2021) A comparison study of lipid and polymeric nanoparticles in the nasal delivery of meloxicam: Formulation, characterization, and in vitro evaluation. International Journal of Pharmaceutics 604, pages 120724.
Crossref
Samar O El-Ganainy, Mennatallah A Gowayed, Mahmoud Agami, Passant Mohamed, Marwa Belal, Ragwa M Farid & Amira S Hanafy. (2021) Galantamine nanoparticles outperform oral galantamine in an Alzheimer’s rat model: pharmacokinetics and pharmacodynamics. Nanomedicine 16:15, pages 1281-1296.
Crossref
. 2021. Nanomaterials: Evolution and Advancement towards Therapeutic Drug Delivery (Part II). Nanomaterials: Evolution and Advancement towards Therapeutic Drug Delivery (Part II) 1 56 .
Hetal P. Patel, Priyanka S. Chaudhari, Priyanshi A. Gandhi, Bhargavi V. Desai, Ditixa T. Desai, Praful P. Dedhiya, Bhavin A. Vyas & Furqan A. Maulvi. (2021) Nose to brain delivery of tailored clozapine nanosuspension stabilized using (+)-alpha-tocopherol polyethylene glycol 1000 succinate: Optimization and in vivo pharmacokinetic studies. International Journal of Pharmaceutics 600, pages 120474.
Crossref
Anna Froelich, Tomasz Osmałek, Barbara Jadach, Vinam Puri & Bozena Michniak-Kohn. (2021) Microemulsion-Based Media in Nose-to-Brain Drug Delivery. Pharmaceutics 13:2, pages 201.
Crossref
Farrukh Zeeshan, Dinesh Kumar Mishra & Prashant Kesharwani. 2021. Theory and Applications of Nonparenteral Nanomedicines. Theory and Applications of Nonparenteral Nanomedicines 153 180 .
Zachary Warnken, Yang Lu, Hugh D. C. Smyth & Robert O. WilliamsIIIIII. 2021. Nanomedicines for Brain Drug Delivery. Nanomedicines for Brain Drug Delivery 209 233 .
Parasuraman Padmanabhan, Mathangi Palanivel, Ajay Kumar, Domokos Máthé, George K. RaddaKah-Leong Lim & Balázs Gulyás. (2020) Nanotheranostic agents for neurodegenerative diseases. Emerging Topics in Life Sciences 4:6, pages 645-675.
Crossref
Javed Ahmad, Md. Rizwanullah, Saima Amin, Musarrat Husain Warsi, Mohammad Zaki Ahmad & Md. Abul Barkat. (2020) Nanostructured Lipid Carriers (NLCs): Nose-to-Brain Delivery and Theranostic Application. Current Drug Metabolism 21:14, pages 1136-1143.
Crossref
Gülcem Altinoglu & Terin Adali. (2020) Alzheimer’s Disease Targeted Nano-Based Drug Delivery Systems. Current Drug Targets 21:7, pages 628-646.
Crossref
Shadab Md, Shahid Karim, Sanggetha R. Saker, Ooi A. Gie, Lim C. Hooi, Phua H. Yee, Alvin W.C. Kang, Chen K. Zhe, Ng Ian, Hibah M. Aldawsari, Khaled M. Hosny & Nabil A. Alhakamy. (2020) Current Status and Challenges in Rotigotine Delivery. Current Pharmaceutical Design 26:19, pages 2222-2232.
Crossref
Gábor Katona, György Tibor Balogh, Gergő Dargó, Róbert Gáspár, Árpád Márki, Eszter Ducza, Anita Sztojkov-Ivanov, Ferenc Tömösi, Gábor Kecskeméti, Tamás Janáky, Tamás Kiss, Rita Ambrus, Edina Pallagi, Piroska Szabó-Révész & Ildikó Csóka. (2020) Development of Meloxicam-Human Serum Albumin Nanoparticles for Nose-to-Brain Delivery via Application of a Quality by Design Approach. Pharmaceutics 12:2, pages 97.
Crossref
Parisa Dehghani, Vahid Jahed & Ali Zarrabi. 2020. Neural Regenerative Nanomedicine. Neural Regenerative Nanomedicine 1 23 .
Amita Sarwal, Gurpreet Singh, Priya Prasad, Sachin Sharma & Waseem Ali. 2020. Nanoformulations in Human Health. Nanoformulations in Human Health 187 203 .
Srishti Mittal, Vanshika Singh & Shweta Dang. 2020. Nanoformulations in Human Health. Nanoformulations in Human Health 435 448 .
Carlos Crespo, Teresa Liberia, José Miguel Blasco‐Ibáñez, Juan Nácher & Emilio Varea. (2018) Cranial Pair I: The Olfactory Nerve. The Anatomical Record 302:3, pages 405-427.
Crossref
C. Costa, J.N. Moreira, M.H. Amaral, J.M. Sousa Lobo & A.C. Silva. (2019) Nose-to-brain delivery of lipid-based nanosystems for epileptic seizures and anxiety crisis. Journal of Controlled Release 295, pages 187-200.
Crossref
Fabio Sonvico, Adryana Clementino, Francesca Buttini, Gaia Colombo, Silvia Pescina, Silvia Stanisçuaski Guterres, Adriana Raffin Pohlmann & Sara Nicoli. (2018) Surface-Modified Nanocarriers for Nose-to-Brain Delivery: From Bioadhesion to Targeting. Pharmaceutics 10:1, pages 34.
Crossref
Shadab Md, Subrat K. Bhattmisra, Farrukh Zeeshan, Naiyer Shahzad, Md Ali Mujtaba, Venkata Srikanth Meka, Ammu Radhakrishnan, Prashant Kesharwani, Sanjula Baboota & Javed Ali. (2018) Nano-carrier enabled drug delivery systems for nose to brain targeting for the treatment of neurodegenerative disorders. Journal of Drug Delivery Science and Technology 43, pages 295-310.
Crossref
Mrunali R. Patel, Rashmin B. Patel & Shivam D. Thakore. 2018. Applications of Nanocomposite Materials in Drug Delivery. Applications of Nanocomposite Materials in Drug Delivery 667 700 .
Dignesh Khunt, Brijesh Shah & Manju Misra. (2017) Role of butter oil in brain targeted delivery of Quetiapine fumarate microemulsion via intranasal route. Journal of Drug Delivery Science and Technology 40, pages 11-20.
Crossref
Yogesh K. Katare, Justin E. Piazza, Jayant Bhandari, Ritesh P. Daya, Kosalan Akilan, Madeline J. Simpson, Todd Hoare & Ram K. Mishra. (2017) Intranasal delivery of antipsychotic drugs. Schizophrenia Research 184, pages 2-13.
Crossref
Jean Cornier, Andrew Owen, Arno Kwade & Marcel Van de Voorde. 2017. Pharmaceutical Nanotechnology: Innovation and Production. Pharmaceutical Nanotechnology: Innovation and Production 633 648 .
Brijesh Shah, Dignesh Khunt, Manju Misra & Harish Padh. (2016) “Application of Box-Behnken design for optimization and development of quetiapine fumarate loaded chitosan nanoparticles for brain delivery via intranasal route* ”. International Journal of Biological Macromolecules 89, pages 206-218.
Crossref
Dina Morshedi & Mahour Nasouti. (2016) Essential Oils May Lead α -Synuclein towards Toxic Fibrils Formation . Parkinson's Disease 2016, pages 1-10.
Crossref
Tian-Tian Zhang, Wen Li, Guanmin Meng, Pei Wang & Wenzhen Liao. (2016) Strategies for transporting nanoparticles across the blood–brain barrier. Biomaterials Science 4:2, pages 219-229.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.